Elliott B. Grossbard
2011
In 2011, Elliott B. Grossbard earned a total compensation of $1.1M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $292,005 |
|---|---|
| Option Awards | $322,082 |
| Salary | $486,675 |
| Other | $5,148 |
| Total | $1,105,910 |
Grossbard received $486.7K in salary, accounting for 44% of the total pay in 2011.
Grossbard also received $292K in non-equity incentive plan, $322.1K in option awards and $5.1K in other compensation.
Rankings
In 2011, Elliott B. Grossbard's compensation ranked 5,301st out of 10,747 executives tracked by ExecPay. In other words, Grossbard earned more than 50.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,301 out of 10,747 | 51st |
Division Manufacturing | 1,922 out of 3,960 | 52nd |
Major group Chemicals And Allied Products | 417 out of 1,033 | 60th |
Industry group Drugs | 261 out of 781 | 67th |
Industry Pharmaceutical Preparations | 205 out of 571 | 64th |
Source: SEC filing on April 8, 2014.
Grossbard's colleagues
We found four more compensation records of executives who worked with Elliott B. Grossbard at Rigel Pharmaceuticals in 2011.
2011
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2011
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2011
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2011
Ryan Maynard
Rigel Pharmaceuticals